** Aveanna Healthcare Holdings' AVAH.O shares rise 17.1% to $4.38 during pre-market trading
** Atlanta-based company expects FY25 rev to be between $2.10 - $2.12 billion, mid-point of which is in line with analysts' estimates of $2.11 billion - LSEG
** Co posts Q4 revenue of $519.9 million, beating analyst estimates of $499.6 million
** "We expect continued organic volume growth, improved clinical outcomes, and enhanced profitability into 2025" - CFO Matt Buckhalter
** Including session's gain, co's shares down about 18% YTD
(Reporting by Bageshri Banerjee)
((bageshri.banerjee@thomsonreuters.com; Ph: 7003700554))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.